The potential impact of new generation transgenic methods on creating rabbit models of cardiac diseases

Since the creation of the first transgenic rabbit thirty years ago, pronuclear microinjection remained the single applied method and resulted in numerous important rabbit models of human diseases, including cardiac deficiencies, albeit with low efficiency. For additive transgenesis a novel transposo...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Bősze Zsuzsanna
Major Péter
Baczkó István
Odening K. E.
Bodrogi Lilla
Hiripi László
Varró András
Dokumentumtípus: Cikk
Megjelent: 2016
Sorozat:PROGRESS IN BIOPHYSICS AND MOLECULAR BIOLOGY 121 No. 2
doi:10.1016/j.pbiomolbio.2016.05.007

mtmt:3068745
Online Access:http://publicatio.bibl.u-szeged.hu/15889
LEADER 02212nab a2200289 i 4500
001 publ15889
005 20190705082210.0
008 190628s2016 hu o 0|| angol d
022 |a 0079-6107 
024 7 |a 10.1016/j.pbiomolbio.2016.05.007  |2 doi 
024 7 |a 3068745  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a angol 
100 1 |a Bősze Zsuzsanna 
245 1 4 |a The potential impact of new generation transgenic methods on creating rabbit models of cardiac diseases  |h [elektronikus dokumentum] /  |c  Bősze Zsuzsanna 
260 |c 2016 
300 |a 123-130 
490 0 |a PROGRESS IN BIOPHYSICS AND MOLECULAR BIOLOGY  |v 121 No. 2 
520 3 |a Since the creation of the first transgenic rabbit thirty years ago, pronuclear microinjection remained the single applied method and resulted in numerous important rabbit models of human diseases, including cardiac deficiencies, albeit with low efficiency. For additive transgenesis a novel transposon mediated method, e.g., the Sleeping Beauty transgenesis, increased the efficiency, and its application to create cardiac disease models is expected in the near future. The targeted genome engineering nuclease family, e.g., the zink finger nuclease (ZFN), the transcription activator-like effector nuclease (TALEN) and the newest, clustered regularly interspaced short palindromic repeats (CRISPR) with the CRISPR associated effector protein (CAS), revolutionized the non-mouse transgenesis. The latest gene-targeting technology, the CRISPR/CAS system, was proven to be efficient in rabbit to create multi-gene knockout models. In the future, the number of tailor-made rabbit models produced with one of the above mentioned methods is expected to exponentially increase and to provide adequate models of heart diseases. 
700 0 1 |a Major Péter  |e aut 
700 0 1 |a Baczkó István  |e aut 
700 0 1 |a Odening K. E.  |e aut 
700 0 1 |a Bodrogi Lilla  |e aut 
700 0 1 |a Hiripi László  |e aut 
700 0 1 |a Varró András  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/15889/1/Bosze-et-al-ProgBiophys2016.pdf  |z Dokumentum-elérés  
856 4 0 |u http://publicatio.bibl.u-szeged.hu/15889/7/Bosze%20et%20al%20PBMB%202016.pdf  |z Dokumentum-elérés